Clinical Trial Update: Open-Label C1 Esterase Inhibitor (C1INH-nf) for the Treatment of Acute Hereditary Angioedema (HAE) Attacks [Phase 3]

View source ↗

Summary

Phase 3 open-label trial of C1 esterase inhibitor (C1INH-nf) for acute hereditary angioedema attacks completed with results posted in 2010.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hereditary Angioedema

Drugs mentioned

• C1 Esterase Inhibitor (C1INH-nf) (C1 esterase inhibitor)

Snippet

Sponsor: Shire | Conditions: Hereditary Angioedema | Phase 3 | Status: COMPLETED | Results posted: 2010-06-09